Publicaciones en las que colabora con S. Casado (71)

2006

  1. Involvement of endothelium and endothelin-1 in lead-induced smooth muscle cell dysfunction in rats

    Kidney International, Vol. 69, Núm. 4, pp. 685-690

2003

  1. Endothelin-1 induced proinflammatory markers in the myocardium and leukocytes of guinea-pigs: Role of glycoprotein IIB/IIIA receptors

    Cardiovascular Research, Vol. 57, Núm. 1, pp. 109-118

  2. Lead-induced downregulation of soluble guanylate cyclase in isolated rat aortic segments mediated by reactive oxygen species and cyclooxygenase-2

    Journal of the American Society of Nephrology, Vol. 14, Núm. 6, pp. 1464-1470

2002

  1. Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: Effect of the α 1 -receptor blocker doxazosin

    Journal of Hypertension, Vol. 20, Núm. 3, pp. 463-470

  2. Aspirin prevents Escherichia coli lipopolysaccharide- and Staphylococcus aureus-induced downregulation of endothelial nitric oxide synthase expression in guinea pig pericardial tissue

    Circulation Research, Vol. 90, Núm. 6, pp. 719-727

  3. Efecto de la inhibición de la HMG-CoA reductasa sobre la proteína inductora de disfunción endotelial en conejos hipercolesterolémicos

    Revista Espanola de Cardiologia, Vol. 55, Núm. 11, pp. 1151-1158

  4. Endotelina-1 estimula la expresión de marcadores pro inflamatorios en miocardio y en células mononucleadas de cobaya. Efectos del bloqueo del receptor glicoproteína IIb/IIIa mediante tirofibán

    Investigacion Cardiovascular, Vol. 5, Núm. 2, pp. 111-131

  5. Expression of estrogen receptor subtypes and neuronal nitric oxide synthase in neutrophils from women and men: Regulation by estrogen

    Cardiovascular Research, Vol. 56, Núm. 1, pp. 43-51

  6. La inhibicíon de la HMG-CoA reductasa protege la funcionalidad del endotelio en conejos hipercolesterolémicos. Comparación con las diferentes estatinas

    Investigacion Cardiovascular, Vol. 5, Núm. 2, pp. 132-145

2001

  1. Alteration of the soluble guanylate cyclase system in the vascular wall of lead-induced hypertension in rats

    Journal of the American Society of Nephrology, Vol. 12, Núm. 12, pp. 2594-2600

  2. Angiotensin II AT1 receptor antagonists and platelet activation

    Nephrology Dialysis Transplantation, Vol. 16, pp. 45-49

  3. Aspirin protected the nitric oxide/cyclic GMP generating system in human peritoneum

    Peritoneal Dialysis International, Vol. 21, Núm. SUPPL. 3

  4. Cerivastatin prevents tumor necrosis factor-α-induced downregulation of endothelial nitric oxide synthase: Role of endothelial cytosolic proteins

    Atherosclerosis, Vol. 155, Núm. 1, pp. 61-70

  5. Doxazosin and soluble guanylate cyclase in a rat model of hypertension

    Revista Espanola de Cardiologia, Vol. 54, Núm. 7, pp. 880-886

  6. Impairment of renal vasodilation with L-arginine is related to more severe disease in untreated hypertensive patients

    Hypertension, Vol. 38, Núm. 4, pp. 907-912

  7. Inhibition of platelet activation in stroke-prone spontaneously hypertensive rats: Comparison of losartan, candesartan, and valsartan

    Journal of Cardiovascular Pharmacology, Vol. 37, Núm. 4, pp. 406-412

  8. Presence of an endothelial dysfunctional inductor protein (EDIP) in the vascular wall of hypercholesterolemic rabbits

    Investigacion Cardiovascular, Vol. 4, Núm. 1, pp. 43-57

  9. Regulation of endothelial nitric oxide synthase expression in the vascular wall and in mononuclear cells from hypercholesterolemic rabbits

    Circulation, Vol. 104, Núm. 15, pp. 1822-1830

  10. Role of type of vascular access in erythropoietin and intravenous iron requirements in haemodialysis

    Nephrology Dialysis Transplantation, Vol. 16, Núm. 11, pp. 2188-2193

2000

  1. 17 Beta-Estradiol-stimulated nitric oxide production by neutrophils: Effect on platelet activation

    Obstetrics and Gynecology, Vol. 95, Núm. 2, pp. 284-290